Bariatric Surgery Associated With Decreased Risk of Developing Cancer
In a population-based study of more than 55,000 patients, bariatric surgery reduced the incidence of de novo cancer by half.
In a population-based study of more than 55,000 patients, bariatric surgery reduced the incidence of de novo cancer by half.
New research could help shed light on the link between the microbiome and disease.
In a first-in-human study, 86% of patients were able to stop insulin after a single electroporation therapy combined with a GLP-1 receptor agonist.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.